CONTINUE TO SITE >

OR WAIT 15 SECS

AMCPAutoimmune DiseasesBiosimilarsCardiovascular DiseasesEyecareHow to Reduce Maternal, Infant Health Risks During COVID-19Improving Ophthalmic Care Access and Treatment Among Aging AdultsMultiple SclerosisSecondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies

Business

Business StrategyConsumersDrug CostsDrug PipelineFormularyHealth ManagementHealth/Disease StrategyHospitals & ProvidersIndustry AnalysisPharmacyPolitics and PolicyPractice ManagementReimbursementTechnology

Clinical

Autoimmune DiseasesBiosimilarsDermatologyDiabetesEyecareLeukemia and LymphomaMental HealthObstetrics-Gynecology & Women's HealthOncologyOpioidsPediatricsPlaque PsoriasisSolid TumorsUrology

News

Media

Expert InterviewsK-CastMedical World NewsPodcasts

Conferences

Publications

Resources

Author | Aubrey Westgate

home
authors
aubrey-westgate

Articles

Ten Things Health Execs Should Know about Lymphoma

May 22, 2018

Slideshow

New treatment approaches could lead to even higher costs associated with lymphoma. However, experts say these treatments hold great promise and could reduce costs in the long-term.